Henry Schein's EBIT per Share for the
three
months ended in Mar. 2026 was $1.63.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $5.80.
During the past 12 months, the average EBIT per Share Growth Rate of Henry Schein was 3.30% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -0.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 5.60% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 3.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Henry Schein's EBIT per Share or its related term are showing as below:
HSIC'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -9.9 Med: 9.05 Max: 57.8
Current: -0.8
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Henry Schein was 57.80% per year. The lowest was -9.90% per year. And the median was 9.05% per year.
HSIC's 3-Year EBIT Growth Rate is ranked worse than 63.21% of 106
companies
in the Medical Distribution industry
Industry Median: 4.1
vs HSIC: -0.80
Henry Schein's EBIT for the
three
months ended in Mar. 2026 was $189 Mil.
Henry Schein (NAS:HSIC) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Henry Schein EBIT per Share Related Terms
Henry Schein EBIT per Share Historical Data
* Premium members only.
The historical data trend for Henry Schein's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.80
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henry Schein (HSIC) has a EBIT per Share of $5.80 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Henry Schein and its competitors. According to the industry distribution chart, Henry Schein ranks #67 out of 106 companies in the Medical Distribution industry, placing it in the top 63.2%.
Is Henry Schein's EBIT per Share too high?
Henry Schein's current EBIT per Share is $5.80. The Medical Distribution industry median EBIT per Share is 4.10. Henry Schein's value of $5.80 is 41.5% above this industry median. Based on the distribution chart, Henry Schein ranks #67 out of 106 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Henry Schein has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's EBIT per Share compare to AHG and ACH?
According to the Medical Distribution industry distribution chart, Henry Schein ranks #67 out of 106 companies for EBIT per Share. This places Henry Schein in the lower half of its industry. The industry median EBIT per Share is 4.10. Henry Schein's value of $5.80 is 41.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Distribution company?
The median EBIT per Share among Medical Distribution companies is 4.10, based on 106 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henry Schein's current EBIT per Share of $5.80 is 41.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Henry Schein and its competitors. For the Medical Distribution industry, the median EBIT per Share is 4.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henry Schein's current EBIT per Share is $5.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Based on GuruFocus' analysis, Henry Schein (HSIC) is currently considered Fairly Valued. The stock's GF Value™ is $83.70, compared to a current price of $84.52 — trading 1% above its estimated fair value. The current EBIT per Share is $5.80 and 41.5% above the Medical Distribution industry median of 4.10. Henry Schein's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Henry Schein (HSIC), the current EBIT per Share is $5.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henry Schein (HSIC) Overvalued in 2026?
Based on GuruFocus' analysis, Henry Schein stock appears to be overvalued.
The current stock price of $84.52 is trading 1% above its estimated GF Value™ of $83.70.
GuruFocus considers Henry Schein to be Fairly Valued.
Key valuation signals for HSIC:
EBIT per Share: $5.80
GF Value™: $83.70 vs. price of $84.52 (1% above fair value)
Industry Position: 41.5% above the Medical Distribution median (#67 of 106)
No single metric tells the full story. See the HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
80GF Score
Get the complete analysis for HSIC
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSIC has been successfully added to your 
